drug companies

In a ruling issued late Monday, Orange County Superior Court Judge Peter J. Wilson found the companies, including Johnson & Johnson, aren't "legally liable" for the opioid crisis.

National

A California court says drug companies aren't liable for the state's opioid crisis

10:54pm November 01, 2021

by Brian Mann

In a ruling issued late Monday, state superior court Judge Peter J. Wilson found the companies, including Johnson & Johnson, aren't "legally liable" for the opioid crisis.

Gilead Sciences, headquartered in Foster City, Calif., makes remdesivir, one of the experimental drugs now being investigated as a possible treatment for COVID-19.

Might The Experimental Drug Remdesivir Work Against COVID-19?

7:19am March 21, 2020

by Sydney Lupkin

It's too soon to know if the antiviral compound tested in 2014 as a potential Ebola treatment will hobble the coronavirus. Lab tests show promise, but studies in people with COVID-19 have only begun.

Millions of Americans sank into addiction after using potent opioid painkillers, such as acetaminophen/oxycodone, that companies churned out and doctors freely prescribed over the past two decades.

National

In 2019, The Legal Fight Over Opioids Unraveled Into Confusion And Infighting

1:47pm December 26, 2019

by Brian Mann

This was meant to be the year we answered a big question about the deadly opioid epidemic: Will drug companies that make and sell prescription pain medications be held liable? That clarity never came.

Loretta Boesing, of Park Hills, Mo., with her son Wesley, who underwent a liver transplant in 2012. Boesing worried the potency of her son's anti-rejection medicine could have been affected by the extremely hot weather when it was delivered.

Health & Safety

Extreme Temperatures May Pose Risks To Some Mail-Order Meds

4:58am January 07, 2019

by Alex Smith

Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.

Queue Listen Now

Marketing payments to doctors by makers of opioids have declined.

Health & Safety

Opioid-Makers Cut Back On Marketing Payments To Doctors

2:40pm June 28, 2018

ProPublica found that drugmakers spent less to market opioids to doctors in 2016 than in prior years. Studies have shown that payments to doctors are linked to more prescriptions for the drugs.

A single company, Purdue Pharma, the maker of OxyContin, funneled $4.7 million to advocacy groups over the five-year period, according to the report.

Health & Safety

Drugmakers Spent Millions Promoting Opioids To Patient Groups, Senate Report Says

11:54am February 13, 2018

by Scott Neuman

The report released by Missouri Democratic Sen. Claire McCaskill says the cozy relationship between pain advocacy groups and pharmaceutical companies may have played a key role in the opioid crisis.

Gregory Matthews has glaucoma and uses prescription eyedrops. The dropper's opening creates a bigger drop than he needs, causing him to run out of his medication before the prescription is ready to refill.

Health & Safety

Drug Companies Make Eyedrops Too Big, And You Pay For The Waste

3:00pm October 18, 2017

by Marshall Allen

When eyedrops dribble down your face, it's not your fault. Drugmakers have long known that their drops of medicine exceed the capacity of the human eye. Why didn't companies make the drops smaller?